Daily News Podcast

Antibody cleared amyloid plaques, slowed cognitive decline

Publish date: July 27, 2018

 

An experimental agent slowed cognitive decline and cleared Alzheimer’s plaques. Can meteorology predict migraines? Why closing a patent foramen ovale is the right approach to prevent recurring ischemic stroke. And claims that cannabis relieves noncancer pain go up in smoke.

Listen to the MDedge Daily News for today’s top news.

Recommended Reading

Dementia epidemiology in LGB community examined for first time
MDedge Psychiatry
Gates Foundation, Lauder family launch $30 million Alzheimer’s biomarker search
MDedge Psychiatry
Pregnancy and years of reproductive capability linked to dementia risk
MDedge Psychiatry
New studies expand on Aimovig for migraine
MDedge Psychiatry
How to prescribe effectively for opioid use disorder
MDedge Psychiatry
Is fish oil’s heart benefit a fish tale?
MDedge Psychiatry
Mild cognitive impairment risk slashed by 19% in SPRINT MIND
MDedge Psychiatry
Monoclonal antibody slowed cognitive decline, cleared Alzheimer’s plaques in phase 2 trial
MDedge Psychiatry
Blood pressure meds cut cognitive impairment risk
MDedge Psychiatry
Alzheimer’s trial design problem throws a wrench in promising BAN2401 results
MDedge Psychiatry